New bandages could help to treat diabetic and burn wounds
- University of Sheffield engineers have developed new dressings that could boost the healing process in patients with burns injuries or chronic wounds
- New dressings contain an agent that helps to form new blood vessels - a critical part of the healing process
- People with diabetes often experience chronic wounds that are difficult to heal and can lead to amputations
- Dressings could also be more affordable and accessible for patients in developing countries where there is an urgent need for such treatments
New dressings that could be used to treat diabetic wounds and burns injuries more effectively have been developed by engineers from the University of Sheffield.
The cotton-based dressings, developed by Professor Sheila MacNeil from the University’s Department of Materials Science and Engineering, release an agent that promotes the formation of new blood vessels - a crucial part of the healing process.
Developed as a collaboration with researchers in Pakistan, the new bandages could also be more affordable and accessible for patients in developing countries where there is an urgent need for dressings to treat chronic wounds caused by diabetes, as well as burns injuries.
With a population of more than 200 million and a struggling economy, affordable healthcare is a major challenge for Pakistan. In developing countries like Pakistan, surgeons and patients do not have access to advanced wound care dressings due to their high price.
Following discussions with surgeons in hospitals and burns units in Pakistan, the research team found that a safe and effective dressing, which can accelerate wound healing, and which does not stick to the wound and acts as a barrier layer to prevent infection from external pathogens, is urgently needed.
There are more than 5.2 million people with diabetes in Pakistan and over 422 million diabetic patients around the world. For patients with diabetes, around 15 per cent will develop diabetic ulcers on their feet or lower legs.
Diabetic ulcers are very difficult to heal and a failure to heal can often progress to amputation. Diabetic wounds are also the leading cause of amputations in the United States.
There are 147 burn injury patients per 100,000 emergency visits in Pakistan. For patients with superficial or partial burns, the challenge is to achieve rapid wound healing to avoid problems of sepsis, scarring and contraction.
Angiogenesis - the formation of new blood vessels - is an important stage of the normal wound healing process, but this is impaired in all chronic wounds. In the case of burns injuries, the upper skin layer is damaged which also disrupts the formation of new blood vessels.
The team of researchers has tested two new types of dressings loaded with a pro-angiogenic agent named 2-deoxy-D-ribose (2dDR) that has been reported to promote the formation of new blood vessels. They discovered that both types of dressings - a non-woven cotton dressing and a cotton wax dressing - stimulated blood vessel formation in a fertilized chick egg model.
Professor Sheila MacNeil, Emeritus Professor of Tissue Engineering at the University of Sheffield’s Department of Materials Science and Engineering, said: “Chronic wounds can be a huge problem for people with diabetes. Once they develop they can be difficult to treat, even more so for people in developing countries who can’t afford to access advanced healthcare. In the worst cases these wounds can lead to amputation.
“The new dressings we are developing are demonstrating the potential to treat these wounds more effectively than the current treatment methods. The non-woven cotton fibres would be ideal for treating chronic wounds and ulcer wounds because of their good absorption capacity, while the 2dDR containing cotton wax dressing would be more appropriate for treating burn wounds because of its non-adhesive properties.
“We’re now hoping to continue our research in Pakistan and run first in man safety studies before clinical trials to bring the dressings a step closer to being available for patients and healthcare systems.”
The research was a collaboration between researchers from the Interdisciplinary Research Centre in Biomedical Materials at COMSATS University Islamabad, Lahore Campus, led by Dr Muhammad Yar, and researchers from the University of Sheffield’s Department of Materials Science and Engineering (Dr Anthony Bullock and PhD student Mr Serkan Dikici). The collaboration also involved clinicians in Pakistan and a major dressings manufacturer in Pakistan - Cotton Craft Limited, Lahore.
Findings from the study have also been published in the Journal of Tissue Engineering and Regenerative Medicine. To access the paper, visit: https://onlinelibrary.wiley.com/doi/abs/10.1002/term.3072
The University of Sheffield
With almost 29,000 of the brightest students from over 140 countries, learning alongside over 1,200 of the best academics from across the globe, the University of Sheffield is one of the world’s leading universities.
A member of the UK’s prestigious Russell Group of leading research-led institutions, Sheffield offers world-class teaching and research excellence across a wide range of disciplines.
Unified by the power of discovery and understanding, staff and students at the university are committed to finding new ways to transform the world we live in.
Sheffield is the only university to feature in The Sunday Times 100 Best Not-For-Profit Organisations to Work For 2018 and for the last eight years has been ranked in the top five UK universities for Student Satisfaction by Times Higher Education.
Sheffield has six Nobel Prize winners among former staff and students and its alumni go on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields.
Global research partners and clients include Boeing, Rolls-Royce, Unilever, AstraZeneca, Glaxo SmithKline, Siemens and Airbus, as well as many UK and overseas government agencies and charitable foundations.
For further information please contact:
Media Relations Officer
University of Sheffield
0114 222 9852